MedTrace Logo

TRADE Trial - Tree Nut Immunotherapy Route Development and Evaluation

NCT05521711 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-06-03

No results posted yet for this study

Summary

Tree nut immunotherapy Route Assessment and DEvelopment (TRADE) is a randomized controlled trial that evaluates the efficacy and safety of sublingual immunotherapy and lower, more tolerable, doses of oral immunotherapy than currently in use.

Conditions

Interventions

OTHER

Food

Commercially available powders or liquids

Sponsors & Collaborators

  • AAAAI Foundation

    collaborator UNKNOWN

  • Hamilton Health Sciences Corporation

    lead OTHER

Principal Investigators

  • Derek Chu, MD PhD FRCPC · Hamilton Health Sciences & McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2026-11-01
Completion
2027-01-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05521711 on ClinicalTrials.gov